chr2-74378079-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PP3_Strong
The NM_004082.5(DCTN1):c.200G>A(p.Gly67Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004082.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Perry syndrome Pathogenic:1Uncertain:1
- -
The c.200G>A variant in DCTN1 (NM_004082.4) predicts a glycine-to-aspartic acid substitution at codon 67 (p.G67D). This variant was present in two siblings of an Argentine family with Perry Disease and absent in an asymptomatic brother. Ages of onset for affected individuals were: 55 and 56 years. There are two additional families with this variant reported in the literature (Aji et al, 2013; Chung et al, 2014). According to ACMG guidelines (Richards, 2015) this variant can be classified as "pathogenic" (supporting evidence PM1, PM2, PP1, PP3, PP4_strong, PP5). Functional studies were not performed yet. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at